Momentum stocks like China Biologic are the place to be, but also keep your eye on takeover candidates among value stocks like Lattice Semiconductor. Read More

Family-run businesses make the best investments and this grocery-store chain has the added catalyst of a retiring patriarch and takeover speculation. Read More

A Greek debt default and possible exit from the Euro has U.S. stocks in a volatile frame of mind, but stronger economic growth and a possible delay in the Fed's first rate hike should calm things down quickly. Double-bottom buy signal? Read More

First-quarter GDP weakness plus merger mania equals low stock-market volatility and continued gains as investors climb a wall of worry concerning the Fed's first interest rate hike in nine years scheduled for later this autumn. Read More

Evidence that U.S. economic growth will accelerate in future quarters suggests that the long dark winter of discontent for cyclical stocks is coming to an end and bargain purchases of cyclicals should occur now before these stocks rebound strongly alongside a stronger economy. Read More

Selling shareholders who don't understand the difference between fundamental business weakness and short-term accounting timing issues have presented savvy long-term investors with a tremendous buying opportunity in 5.3% yielding Harte-Hanks. Read More

With the Nasdaq finally hitting a new all-time high, the risk appetite of investors is high and small caps will continue to outperform. A likely interest-rate hike by the Federal Reserve sometime in 2015 will not stop the small-cap juggernaut from moving to higher highs. Read More